MYHIXEL Control II is a ~$199 male masturbator paired with an 8-week AI-guided app training program, made by Spanish brand MYHIXEL and built specifically to treat premature ejaculation through Sphincter Control Training (SCT). Unlike the broader male pleasure market, MYHIXEL is structured as a medical-adjacent device: FDA-listed as a Class II medical device, CE-marked in the EU, and backed by a multi-center randomized controlled trial published in peer-reviewed sexual medicine literature. The product consolidates MYHIXEL's earlier split lineup (MYHIXEL TR for stamina training, MYHIXEL Med for diagnosed PE) into a single flagship device and app program as of 2025.

Why It Matters

MYHIXEL sits at the intersection of the pleasure device category and the medical device category — one of the very few male pleasure products with the regulatory clearance and clinical evidence to be considered a legitimate PE treatment. As telehealth platforms like Hims and Roman expand into PE treatment via SSRIs and topicals, MYHIXEL's behavioral-plus-hardware approach represents a drug-free alternative that may appeal to users wary of pharmaceutical side effects. The 8-week structure is also a subscription-adjacent business model — once users complete the program, upsell into mentoring, premium content, or ongoing coaching is straightforward.

The hardware: a Bluetooth-connected stroker with vibration and warming (up to body temperature), a textured silicone sleeve, and pressure sensors that feed data back to the companion app. The app guides users through an 8-week cognitive-behavioral training program combining edging techniques, breathing exercises, and pelvic floor control — all integrated with the device so the user gets real-time feedback on arousal thresholds and sphincter control. Specs include USB charging, IPX7 waterproofing, app compatibility for iOS and Android, and MYHIXEL's clinical evidence library available inside the app.

The clinical data is the selling point and separates MYHIXEL from the rest of the male stroker category. A multi-center RCT published in sexual medicine literature showed that users completing the SCT program achieved up to 7x longer ejaculation latency, with 60% of participants no longer meeting clinical PE diagnostic criteria after the 8-week program. No side effects were observed, and the training required no partner involvement — addressing a common barrier in PE treatment research. By contrast, SSRI-based treatments (the pharmaceutical standard for PE) have substantial side-effect profiles and require daily medication.

Reviews capture the honest tradeoff. Mel Magazine's review acknowledged the clinical credibility but noted that much of the behavioral protocol could theoretically be self-taught with a standard Fleshlight and freely available cognitive-behavioral guidance. FemTech Insider and Premature Ejaculation Help concluded that for users willing to commit to an 8-week structured program, the integrated hardware-plus-app approach delivers meaningfully better adherence than DIY — which is where clinical behavioral programs typically fail. The Private Gym review called it "the edging trainer for sexual stamina" and highlighted that the app's real-time biofeedback is genuinely useful for novice users who don't know their own arousal thresholds.

Price and availability: $199 direct from MYHIXEL.com, also sold through menMD (US-focused men's health retailer), Amazon, and select sexual health specialty retailers. Often bundled with the MYHIXEL hydration gel and replacement sleeves. 1-year device warranty plus access to the app program. Ships in discreet medical-grade packaging.

Materials: medical-grade silicone sleeve (body-safe, phthalate-free, non-porous), ABS plastic body. Sleeve is removable and boilable for sterilization. Compatible with water-based lube only.

The bottom line: buy MYHIXEL Control if premature ejaculation is a real issue you want to address and you're willing to commit to an 8-week structured program. The clinical evidence is legitimately better than anything else in the stroker category, and the integrated hardware-app pairing addresses adherence — the real barrier to behavioral PE treatment. Skip it if you want a standard pleasure stroker (any Arcwave, TENGA Flip, or Fleshlight is a better entertainment value), or if you already know your PE triggers and have access to pelvic-floor physical therapy. The alternative "Melonga app" (covered in the March CLIMACS study at EAU26) is a smartphone-only version of the same behavioral protocol at lower cost — that's the cheaper entry point if you don't want the hardware.

Sources

Update — 2026-04-24

Initial entry — product guide first created.